Combination Therapy for Patients With Nasopharyngeal Carcinoma

During a live event, Deborah Wong, MD, PhD, discussed the role of PD-1 inhibitors in nasopharyngeal cancer and their accessibility/safety.

During a live event, Deborah Wong, MD, PhD, discussed the role of EBV and challenges in nasopharyngeal cancer diagnosis with event participants.

Deborah Wong, MD, PhD, discusses the toripalimab combination that is now considered standard of care in nasopharyngeal cancer.

Deborah Wong, MD, PhD, discusses therapeutic options for patients with nasopharyngeal carcinoma.